Unibest

Pharmaceutical intermediates

Micafungin Sodium Intermediates

1 pharmaceutical intermediate for Micafungin Sodium. Indication: Candidiasis; Fungal infection; Candidemia; Peritonitis; Pyrexia.

Submit a ProjectAll intermediates

About Micafungin Sodium

Originator
Astellas Pharma Inc.
Indication
Candidiasis; Fungal infection; Candidemia; Peritonitis; Pyrexia
Approved Date
06/27/2006

Available intermediates

1 intermediate currently listed for Micafungin Sodium. Request specifications, documentation or a quotation for any item below.

Micafungin Sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoic acid179162-55-1//

Other programs under M

MaribavirMaxacalcitolMetoclopramide HClMilvexianMirogabalin besilateMolnupiravirMomelotinib Dihydrochloride MonohydrateMoxifloxacin hydrochloride

Building toward Micafungin Sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →